Virtual Reality Relaxation for Addiction Inpatients

Sponsor
Karolinska Institutet (Other)
Overall Status
Suspended
CT.gov ID
NCT04293978
Collaborator
Stockholm University (Other)
40
1
1
22.3
1.8

Study Details

Study Description

Brief Summary

This trial examines the immediate session effect of Virtual Reality (VR) relaxation, when used at an addiction inpatient ward for adolescents.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: CalmPlace
N/A

Detailed Description

Past research has revealed that Virtual Reality nature environments can be used to induce relaxation, yet this type of intervention has not yet been evaluated in a clinical setting. This trial examines whether VR relaxation can be used as a digital equivalent of a (physical) comfort room at an an addiction inpatient ward for adolescents.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Single-arm, with immediate effects of interest. Varying number of intervention uses across participants.Single-arm, with immediate effects of interest. Varying number of intervention uses across participants.
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Virtual Reality Relaxation at an Adolescent Addiction Inpatient Ward: A Single-arm Pilot Trial
Actual Study Start Date :
Feb 21, 2020
Anticipated Primary Completion Date :
Jun 30, 2021
Anticipated Study Completion Date :
Dec 31, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Virtual Reality relaxation

Participants may request to use the application at any time during their stay at the ward, as many times as they wish. Participants sign in using an anonymous study ID and sessions (and outcomes) are automatically logged by the device to this ID.

Behavioral: CalmPlace
Self-contained VR application allowing the user to build and custom a relaxation session, with options to vary session length (9-20 minutes), music/sound, relaxation exercises, and specific nature environment (three available) including time of day and events (e.g. rain). Delivered using an Oculus Go devices in kiosk-mode.

Outcome Measures

Primary Outcome Measures

  1. Change from baseline in general well-being [Change from baseline (start of session) to immediately after the intervention]

    Rated 0-100 using a visual analogue scale with smiley-type anchors (higher score is better outcome).

Eligibility Criteria

Criteria

Ages Eligible for Study:
15 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patient at Maria Ungdom inpatient ward.

  • Sufficient grasp of Swedish to understand terms of study participation and intervention instructions.

Exclusion Criteria:
  • Self-reported stereoscopic vision or balance problems hindering VR experience.

  • Self-reported history of repeated violent outbursts when using technology.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Maria Ungdom HeldygnsvƄrd Stockholm Sweden 18354

Sponsors and Collaborators

  • Karolinska Institutet
  • Stockholm University

Investigators

  • Principal Investigator: Philip Lindner, PhD, Karolinska Institutet

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Philip Lindner, Head of Research and Development, Maria Ungdom Clinic, Karolinska Institutet
ClinicalTrials.gov Identifier:
NCT04293978
Other Study ID Numbers:
  • Virtuella Lugna rummet
First Posted:
Mar 3, 2020
Last Update Posted:
Feb 18, 2021
Last Verified:
Feb 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Philip Lindner, Head of Research and Development, Maria Ungdom Clinic, Karolinska Institutet
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 18, 2021